Guidelines for the use of Tes Cepat Molekuler (TCM) for Hepatitis B and Hepatitis C

Overview

Hepatitis B and C virus infection are important global and national health challenges. To prevent transmission, it is necessary to provide guidelines for point-of-care testing (POCT) in detecting HBV DNA and HCV RNA. Aimed at programme managers and healthcare providers, these guidelines are a key resource in enhancing the diagnosis and treatment of hepatitis B and C, significantly improving patient management and care. These guidelines are available in Indonesian language.